Industry Expert Opinion: Bob Neagle
Business Unit Manager for Secondary Packaging (LCM & LPA) at Videojet Technologies
Many countries around the world have put in place laws and regulations mandating that pharmaceutical products be coded and marked to protect against counterfeiting and deliver accurate product information in order to ensure consumer safety. To comply with these regulations, pharmaceutical companies must integrate labeling systems into their packaging lines that generate codes that are easily read by ID readers and people. The tight cost constraints faced by the pharmaceutical industry make it essential to evaluate the total cost of ownership (TCO) of proposed labeling systems in order to ensure compliance with laws and regulations while minimizing both capital and operating costs.